#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangioma Brain abscess Dementia Alzheimer's type Deafness Hereditary angioedema Transitional cell carcinoma Congenital disorder of glycosylation Fibrosarcoma Squamous cell carcinoma of head and neck Angiosarcoma recurrent Stargardt's disease Myxoid liposarcoma Angiosarcoma metastatic Autoinflammation with infantile enterocolitis Meningococcal immunisation More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Diagnostics Sarcoidosis – Basic Information Leiomyosarcoma recurrent – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Progressive supranuclear palsy – Basic Information Idiopathic inflammatory myopathy – Trials in Disease Mantle cell lymphoma stage II – Treatment Cholangitis sclerosing Sarcoidosis – Diagnostics CADASIL – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Letermovir Jnj-81241459 Microcrystalline Cellulose Sodium Sulfate Anhydrous Meloxicam Alks 2680 Holcus Lanatus Pollen Extract Sodium Cromoglicate Fludeoxyglucose (18F) VG801-1 Bupropion Hydrochloride Hydroxypropyl Cellulose Lf Sepiapterin Sodium Hydrogen Carbonate Ivabradine Bms-986315 Tolvaptan Collagenase Cannabis Sativa Flower Betula Pollen Extract More therapies…

    Learn about Your Condition

    Oesophageal cancer metastatic Pseudoxanthoma elasticum Astrocytoma malignant Haemoptysis Kearns-Sayre syndrome Immune-mediated myositis HER2 protein overexpression Post procedural complication Graft infection Follicular lymphoma stage III Tendon rupture Metastases to lymph nodes Cold type haemolytic anaemia Niemann-Pick disease Giardiasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Otorhinolaryngologic Diseases

  • Study on the Effect of Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis without nasal polyps
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Dupilumab
    Austria

  • Study on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deafness neurosensory
    Investigated Drugs:
    • 6-Fluoro-9-Methyl-9H-Pyrido[3,4-B]-Indole
    • Prednisolone
    Austria Czechia Germany The Netherlands Poland

  • Study on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin

    Not recruiting

    2 1
    Investigated Diseases:
    • Deafness neurosensory
    Investigated Drugs:
    • Acou085
    Germany

  • Study on SENS-501 for Children with Severe Hearing Loss Due to Otoferlin Gene Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Deafness bilateral
    Investigated Drugs:
    • Adeno‐Associated Viral Vector Serotype 8 Containing The 3′ Human Otoferlin Coding Sequence
    • Abiraterone Acetate
    • Lidocaine Hydrochloride Monohydrate
    France Germany Italy

  • Study Comparing Dupilumab and Mepolizumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Danish Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Mepolizumab
    • Mometasone Furoate
    • Dupilumab
    Denmark

  • Study on the Effects of Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Dupilumab
    Belgium
Previous Page
1 … 8 9 10 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!